Business Context and Reporting Period
This Form 8-K was filed by Genpact Limited on April 5, 2011, reporting the entry into a Material Definitive Agreement. The filing details a merger transaction involving Genpact International Inc., a wholly-owned subsidiary of Genpact, and Headstrong Corporation.
Key Financial Metrics and Transaction Details
- Transaction Value: Aggregate enterprise value of $550 million in cash, subject to net working capital adjustments.
- Financing Structure: Genpact expects to fund the transaction using existing cash on hand and new borrowings.
- New Debt Facilities: A commitment letter dated April 4, 2011, secures $350 million in new senior secured credit facilities, consisting of a $100 million term loan and a $250 million revolving credit facility.
- Lenders: Citibank, N.A., UBS AG, Singapore Branch, JPMorgan Chase Bank, N.A., Hong Kong Branch, and Bank of America, N.A.
- Operational Impact: Upon completion, Headstrong will become a wholly-owned subsidiary of Genpact International.
Material Changes and Transaction Status
The primary material change is the execution of the Merger Agreement to acquire Headstrong. The filing notes that approval from a majority of Headstrong's outstanding common stock holders has already been obtained via written consent. The transaction does not require approval from Genpact Limited's shareholders.
Outlook, Risks, and Contingencies
- Closing Conditions: Completion is subject to customary conditions, including clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, the absence of a material adverse effect on Headstrong, and the absence of any injunction prohibiting the merger.
- Covenants: The new credit facilities include standard representations, warranties, affirmative and negative covenants, and funding conditions.
- Documentation: The full text of the Merger Agreement is expected to be filed as an exhibit to the Form 10-Q for the quarter ending March 31, 2011.
Investor Verification Checklist
- Verify the final net working capital adjustment to the $550 million enterprise value.
- Confirm the receipt of Hart-Scott-Rodino antitrust clearance.
- Review the full Merger Agreement in the upcoming Form 10-Q for specific covenants and termination fees.
- Monitor the impact of the new $350 million debt facilities on Genpact's leverage ratios and liquidity.